CD68 and Sepsis: In the muscular layer of the small intestine, blocking IL-17A ameliorated sepsis-induced inflammation, as evidenced by a decreased number of CD68+ macrophages and decreased levels of MPO activity (Figures 4(a) and 4(b)).